It’s the end of an era—for pharma TV advertising, anyway. Humira’s reign at the top of the TV ad spenders is over. AbbVie had been ratcheting back the brand’s TV budget over the past few months, but, ...
Image above from a recent Humira ad. The Humira wars have begun, as the first branded biosimilar to break Abbvie’s 20-year exclusivity on the top-selling anti-inflammatory drug has launched, cutting ...
AbbVie's Humira drop didn’t last long. While the blockbuster immunology med dropped out of the No. 1 pharma TV spending spot in March, it bounced right back in April. AbbVie spent almost $23 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results